Masonic Cancer Center announces the appointment of Dr. Melissa Geller to Associate Director
Melissa Geller, MD, MS, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.
Dr. Geller is the new Associate Director (AD) for Clinical Research at the Masonic Cancer Center. Geller, a Professor and Division Director for Gynecologic Oncology in the Department of Obstetrics, Gynecology and Women's Health (OBGYN), and a practicing Gynecologic Oncologist with M Health Fairview takes over for Charles Ryan, MD, who was recently announced as the President and CEO of the Prostate Cancer Foundation. In her new role, Geller oversees the integration of clinical research with clinical activities while providing oversight for the Clinical Shared Resources and the Clinical Trials Office. She will assist in developing and measuring programmatic metrics for efficient process planning and financial management for clinical trials.
“In this new role I am excited to implement innovative approaches to further expand the reach of our clinical trial portfolio with operationally and financially successful research collaborations and projects,” noted Geller. “I am looking forward to collaborating with cancer center leadership to ensure that we are supporting and advancing cancer research for all Masonic Cancer Center members, as well as working closely with the Executive Director for clinical research to set and achieve our priorities for the cancer center.”
“Dr. Geller’s role in translating novel therapies to the clinic is exemplary,” noted Douglas Yee, MD, Director of the Masonic Cancer Center. “Her background in developing investigator-initiated trials, engaging our Clinical Trials Office staff, and collaboration with basic and translational researchers is exactly the type of experience needed to enhance clinical trial conduct.”
Dr. Geller, who specializes in the treatment and management of gynecologic malignancies, will help guide all clinical research efforts at the Masonic Cancer Center.
Dr. Geller’s appointment became effective on October 11, 2021.
Please join us in congratulating Dr. Geller on her new position.
About the Masonic Cancer Center
The Masonic Cancer Center, University of Minnesota, is the Twin Cities’ only Comprehensive Cancer Center, designated ‘Outstanding’ by the National Cancer Institute. As Minnesota’s Cancer Center, we have served the entire state for more than 25 years. Our researchers, educators, and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related diseases. Learn more at cancer.umn.edu